Published in Physician Law Weekly, October 5th, 2005
According to recent research from France, "Neoadjuvant chemotherapy before resection of NSCLC seems to increase survival, mainly in the early stage. Risks of postoperative complications after chemotherapy and surgery remain controversial."
"Here we review our experience with patients treated in one thoracic surgery center. Patients undergoing resection for NSCLC after induction chemotherapy between January 1993 and March 2002 were reviewed. Data collected included age, sex, preoperative forced expiratory volume in 1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.